GC
GEHC icon

Grimes & Company’s GE HealthCare GEHC Stock Holding History

Grimes & Company’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Sell
4,180
-8
-0.2% -$526 0.01% 395
2026
Q1 		$298K Buy
4,188
+37
+0.9% +$2.92K 0.01% 362
2025
Q4 		$340K Sell
4,151
-107
-3% -$8.34K 0.01% 363
2025
Q3 		$320K Buy
4,258
+50
+1% +$3.73K 0.01% 367
2025
Q2 		$312K Buy
4,208
+63
+2% +$4.39K 0.01% 332
2025
Q1 		$335K Buy
4,145
+45
+1% +$3.87K 0.01% 282
2024
Q4 		$321K Sell
4,100
-11
-0.3% -$935 0.01% 302
2024
Q3 		$386K Sell
4,111
-114
-3% -$9.57K 0.01% 258
2024
Q2 		$329K Sell
4,225
-119
-3% -$9.71K 0.01% 263
2024
Q1 		$395K Sell
4,344
-28
-0.6% -$2.33K 0.01% 247
2023
Q4 		$338K Buy
4,372
+38
+0.9% +$2.66K 0.01% 253
2023
Q3 		$295K Sell
4,334
-27
-0.6% -$1.96K 0.01% 243
2023
Q2 		$354K Sell
4,361
-122
-3% -$9.73K 0.01% 233
2023
Q1 		$368K Buy
+4,483
New +$320K 0.02% 225

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Grimes & Company's GEHC Position: Q2 2026 in Review

Grimes & Company reduced its GE HealthCare (GEHC) stake by 0.19% in Q2 2026, selling an estimated $526 and leaving 4,180 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #395.

Grimes & Company first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $395K in Q1 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Grimes & Company held 4,180 shares of GE HealthCare worth $268K as of Q2 2026.
  • Grimes & Company sold 8 GE HealthCare shares in Q2 2026, an estimated $526.
  • GE HealthCare made up 0.01% of Grimes & Company's portfolio in Q2 2026, its #395 holding.
  • Grimes & Company first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Grimes & Company's GE HealthCare position peaked at $395K in Q1 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.